ARCHIVES

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Norris Cotton Cancer Center wins core grant renewal.

October 10, 2003

In Brief: Schwarzkopf In NCCS TV Spot; AACI elects Officers; Nobel Prize In Medicine awarded

October 18, 1996

Lower Stomach Cancers Increasing In Younger U.S. Whites, Study Finds

May 28, 2010

Turmoil in Texas: DePinho Recommended AVEO Stock on CNBC Six Days After FDA Said New Trial Was Needed

May 10, 2013

NCCS Networker Volume 1 Issue 3, Fall 1987

September 13, 1987

Frozen Serum Panels Available For Assays

June 8, 1984